stockportfolio.pro
Stocks / RYTM vs TFX
RYTM vs TFX
Rhythm Pharmaceuticals, Inc. and Teleflex Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Rhythm Pharmaceuticals, Inc. (RYTM) | Teleflex Incorporated (TFX) | |
|---|---|---|
| Market cap | $5.9B | $5.9B |
| Revenue (latest FY) | $189.76M | $1.98B |
| Net income (latest FY) | $-196.54M | $-905.64M |
| Revenue growth (5y CAGR) | — | -4.8% |
| Net margin | -103.6% | -45.7% |
| Return on equity | -72.8% | -29.0% |
| P/E ratio | — | 2657.2 |
| Dividend yield | — | 1.0% |
| Profitable years (of last 10) | 0 | 9 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open RYTM — free Open TFX — freeFrequently asked questions
Which is bigger, RYTM or TFX?
Rhythm Pharmaceuticals, Inc. is larger by market capitalization — $5.9B versus $5.9B.
Which grows faster, RYTM or TFX?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.